NCT00084786View on ClinicalTrials.gov

Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2004

Primary Completion Date

July 31, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

docetaxel

DRUG

gefitinib

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00084786 - Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter